Acorn Wealth Advisors’s Biogen BIIB Stock Holding History

Acorn Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-66	Closed	-$20K	–	149
2018 Q2	$20K	Hold	66	–	–	0.02%	386
2018 Q1	$18K	Hold	66	–	–	0.02%	402
2017 Q4	$22K	Buy	+66	New	+$21.2K	0.02%	362

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acorn Wealth Advisors's BIIB Position: Q3 2018 in Review

Acorn Wealth Advisors sold out of Biogen (BIIB) in Q3 2018, closing a stake of 66 shares — an estimated $20K sold.

Acorn Wealth Advisors first reported a position in BIIB in Q4 2017 and held it in 3 quarters. The position peaked at $22K in Q4 2017. 1,146 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

Acorn Wealth Advisors reported no remaining Biogen position as of Q3 2018 after selling out during the quarter.
Acorn Wealth Advisors sold 66 Biogen shares in Q3 2018, an estimated $20K.
Acorn Wealth Advisors first reported a position in Biogen in Q4 2017 and held it in 3 quarters.
Acorn Wealth Advisors's Biogen position peaked at $22K in Q4 2017.
1,146 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on Acorn Wealth Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.